Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;27 Suppl 1(Suppl 1):113S-118S.
doi: 10.1111/j.1365-2125.1989.tb03471.x.

Vigabatrin in epilepsy in mentally retarded patients

Affiliations

Vigabatrin in epilepsy in mentally retarded patients

R Matilainen et al. Br J Clin Pharmacol. 1989.

Abstract

1. The anticonvulsant potency of vigabatrin (gamma-vinyl GABA, GVG) was studied in an open trial in a group of 21 mentally handicapped patients with drug-resistant epilepsy. 2. With this treatment one third of these patients had more than 50% reduction in seizure frequency. The anticonvulsant effect appeared during the first month of therapy and was maintained during a 7-month study. The side effects were mild: mainly tiredness, aggressiveness, and ataxia. Other anticonvulsant drugs remained at baseline levels during GVG therapy. GVG was not found to modulate EEG recordings. 3. According to our results, GVG is effective for treating intractable epilepsy in mentally handicapped patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuroscience. 1986 May;18(1):61-77 - PubMed
    1. Adv Neurol. 1986;44:343-64 - PubMed
    1. Neurology. 1987 Feb;37(2):184-9 - PubMed
    1. Arch Neurol. 1987 Sep;44(9):907-10 - PubMed
    1. Epilepsia. 1987 Nov-Dec;28(6):688-92 - PubMed